Lexicon Pharmaceuticals | Crediti Commerciali





Crediti Commerciali Cambiamento Data
Abbott USD 10.4B 166M 2025-09
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
AstraZeneca USD 17.56B 1.32B 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Illumina USD 854M 125M 2025-12
Insmed USD 65.26M 10.23M 2025-09
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 17.61B 235M 2025-09
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
MacroGenics USD 69.23M 56.7M 2025-09
MannKind USD 17.38M 9.76M 2025-09
Merck USD 12.12B 596M 2025-09
Moderna USD 1.05B 589M 2025-09
Novartis USD 8.98B 192M 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12


Lexicon Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.